Search

everythinglearnresearchcommunity

for

Search:↓

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Finasteride reduces hair growth and is safe for women with excessive hair.

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

Nanostructured lipid carriers improve minoxidil delivery for hair loss treatment.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Rice bran extract can potentially treat hair loss by promoting hair growth and increasing the number of hair follicles.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Olive leaf compound oleuropein helps grow hair in mice.

Ziziphus jujuba Mills may have health benefits, but more research is needed to confirm its safety and effectiveness.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

MALDI Imaging Mass Spectrometry is a useful method for studying skin conditions, but sample preparation is crucial for accurate results.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.